Barclay Damon Continues to Aggressively Grow its IP Team, Adding Accomplished Life Sciences and Patent Litigators
Vogel and Rifai-Bashjawish Join Henschke to Bring Extensive Client Depth,
AMLAW 100 Experience
September 13, 2017—Barclay Damon continues to expand its noted intellectual property litigation team with the recent additions of Laura A. Vogel, partner, and Hoda Rifai-Bashjawish, associate. They join Marc Henschke, who joined the firm as a partner earlier this year. These appointments demonstrate the firm’s strong and ongoing commitment across the life sciences industry, including to pharmaceutical, biotechnology and medical device companies, by hiring leadings attorneys to provide cutting-edge client solutions.
Laura A. Vogel. Laura has represented pharmaceutical and biotechnology clients in more than 20 Abbreviated New Drug Application (ANDA) cases as litigation counsel or co-counsel. In addition to Hatch-Waxman Act disputes, Laura has been advising clients for 15 years on patent prosecution and portfolio development; due diligence investigations; and freedom-to-operate, patentability, infringement, validity, and inequitable conduct opinions, as well as pre-litigation counseling in pharmaceutical matters. Her practice regularly involves Citizen Petition practice and the analysis of regulatory issues, such as patent-based and FDA-granted exclusivities. Laura represents clients before the US Patent Trial and Appeals Board and has served as counsel in multiple inter partes reviews and interference actions. She has prepared and prosecuted US and foreign patent applications in the areas of biotechnology, pharmaceuticals, food sciences, molecular and cellular biology, recombinant DNA technology, therapeutic proteins, diagnostic assays, gene therapy, vaccines, and tissue sealant technology. A noted speaker, Laura recently presented at the 11th Annual Paragraph IV Disputes ACI Conference and the 4th Annual Conference on Women Leaders in Life Sciences Law. Prior to joining Barclay Damon, Laura was counsel at Wolf, Greenfield & Sacks P.C. and was instrumental in building the Hatch-Waxman practice as an associate and partner at Duane Morris LLP, both in Boston. Laura is admitted to practice in New York, Washington, DC and Massachusetts as well as before the Court of Appeals for the Federal Circuit and is registered to practice before the US Patent and Trademark Office. Click here for more about Laura’s practice, including her representative experience.
Hoda Rifai-Bashjawish. Hoda represents clients in district courts and the Federal Circuit, and before the Patent Trial and Appeal Board and Trademark Trial and Appeal Board. Hoda's dual technical background in biomechanical engineering and physics gives her a thorough understanding of clients’ complex intellectual property in a broad range of technologies. She also has an extensive pro bono practice, which includes representing non-profits and clients in need of access to health care. Prior to law school, Hoda received a Fulbright US Fellowship grant to study bioethics in Damascus, Syria. Hoda started her career as an associate at Skadden, Arps, Slate, Meagher & Flom LLP in New York City. Click here for more about Hoda’s practice, including her representative experience.
Marc N. Henschke. Marc has extensive first-chair experience in jury trials and Markman claim construction hearings and has litigated patent-infringement cases relating to a wide variety of products and technologies, including wireless modules and systems for IOT applications, network switches and routers, computer hardware and software, medical lasers, high-speed data cables, e-commerce applications, business methods, surgical screws, LCD displays, LANs and VLANs, laptop computers, cell phones, digital still cameras, video cameras, PDA devices, and radar detectors. Marc is well versed in strategies for coordinating the interplay between patent litigations and inter partes review proceedings filed with the Patent Trial and Appeal Board. He has also litigated numerous other types of commercial litigation cases in a variety of jurisdictions. Prior to joining Barclay Damon, Marc was a partner at Foley & Lardner LLP in Boston. Click here for more about Marc’s practice, including his representative experience.
John P. Langan, Barclay Damon’s managing partner, said, “We are thrilled to offer our clients the very specialized and in-depth capabilities these skilled practitioners bring. Our IP clients have always received smart, aggressive representation that is second to none. Now with Laura, Hoda, and Marc’s experience in high-demand areas like pharma and other life sciences, coupled with their years of hands-on experience in some of the country’s largest law firms and dedication to their clients’ interests, we can provide clients even greater resources to protect and monetize their valuable intellectual property.”
“The addition of these attorneys brings a new level of understanding of the very complex world in which pharma and biotech executives and inventors do business,” added Douglas J. Nash, chair of the firm’s Intellectual Property Litigation Practice Area. “Backed up by the bench strength of our IP group and our complementary practice areas that can serve virtually any need these clients may face, we offer complete, comprehensive, and seamless representation. Our aim is always to provide progressive and innovative solutions in an ever-changing and increasingly competitive market.”
Laura and Marc are resident in Barclay Damon’s Boston office. Hoda is resident in the Syracuse office.
Barclay Damon LLP, listed as a “Top 250 Firm” by The National Law Journal, is a full-service law firm with offices throughout the major cities of New York State and in Toronto, Boston, Washington DC, and Newark. At 275 lawyers, Barclay Damon is the largest law firm in the Northeastern United States that is not centered in a major market. Barclay Damon provides comprehensive legal and business counsel to a diverse client base in 33 practice areas. For more information, visit barclaydamon.com
- NYS Appellate Court Holds That Whether Provision in Construction Contract Required Additional Insured Coverage Presented Question of Fact
- The 2019-2020 NYS Budget Requires Financial Reporting for Electric Generators
- US Department of Labor Proposes Rule to Update and Clarify “Regular Rate” Requirements
- Unexecuted Indemnification Agreement Not Retroactive Once Executed